DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
1.835
-0.035 (-1.87%)
At close: Aug 1, 2025, 4:00 PM
1.830
-0.005 (-0.26%)
After-hours: Aug 1, 2025, 7:55 PM EDT
Chimerix Employees
DURECT had 21 employees as of December 31, 2024. The number of employees decreased by 37 or -63.79% compared to the previous year.
Employees
21
Change (1Y)
-37
Growth (1Y)
-63.79%
Revenue / Employee
$88,381
Profits / Employee
-$233,952
Market Cap
56.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | -37 | -63.79% |
| Dec 31, 2023 | 58 | -21 | -26.58% |
| Dec 31, 2022 | 79 | 0 | - |
| Dec 31, 2021 | 79 | -2 | -2.47% |
| Dec 31, 2020 | 81 | -9 | -10.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DRRX News
- 3 days ago - Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - Benzinga
- 4 days ago - Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - Accesswire
- 2 months ago - DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire
- 6 months ago - DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 6 months ago - DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - PRNewsWire